Recruiting

Treatment Preferences

Sponsor:

Sir Mortimer B. Davis - Jewish General Hospital

Code:

NCT04925154

Conditions

Patient Preference

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

The only intervention will be the information brochure that will be given after the first questionnaire.

Study Details

Brief summary:

This study is aiming to look into patients' treatment preferences and their socio economic background as well as the exploration of thought processes leading to these preferences. It will integrate, in two exploratory questionnaires, the three most common treatment schema (standard of care, non-operative management, surgery alone) all of which have been demonstrated efficacious.

Conditions

Patient Preference

Study ID

NCT04925154

Start date

Dec 13, 2021

Status verified date

May, 2025

Completion date

Jan 1, 2028

Anticipated

Primary completion date

Dec 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

Group A

  • New rectal cancer patient
  • Operable patients
  • Capable adults older than 18 years of age
  • Capacity to sign a consent form
  • Capacity to answer questionnaires on an online platform Group B
  • Treating physician specialists
  • Capacity to sign a consent form
  • Capacity to answer questionnaires on an online platform

Exclusion Criteria:

Group A:

  • Patient unable to sign a consent form
  • Patients with metastasis
  • Recurrent tumours
  • Inability to answer questionnaires on an online platform
  • Inability to communicate in french or english

Group B:

  • Participant unable to sign a consent form
  • Inability to answer questionnaires on an online platform

Study Design

Enrollment

192 participants

Anticipated

Interventions and Outcome Measures

Arms

Group A: Patients

Recruitment for this group will take place at either the radiation-oncology department or at the colorectal surgery department, at the time of consultation or at the time of diagnosis, before the treatment setting. Once clinical staging is available, the surgeon and/or radiation-oncologist and/or research assistant should identify eligible patients. Patients that comply with selection criteria (inclusion/exclusion) will be approached by a research team member. For those patients interested in participating, the e-link to the consent form for this group will be sent by email. Once a patient decides to sign the consent form, the link for the questionnaire Q1 will be sent by email.

Group B: Physicians

Health professionals will be approached by the research team. The study aim will be explained, and participants that agree to participate will be provided an e-link to consent for this group. Once the health care participant decides to sign the consent form, the link for the questionnaire Q1 will be sent by email.

Interventions

The only intervention will be the information brochure that will be given after the first questionnaire.

The information brochure will be given to both groups at the same time at 2-3 weeks after the first consultation (patients group) or after answering the first questionnaire (physicians group).

Primary outcome measure

  • Socio-economic and demographic characteristics [ Time Frame: 1 day ]

Central Contacts and Locations

Central contacts

Emma Starr, BHSc

514-340-8222emma.starr.ccomtl@ssss.gouv.qc.ca

Locations

Jewish General Hospital

Recruiting

Montreal, Quebec, Canada, H3T 1E2

Contacts

Té Vuong, MD

514-340-8222te.vuong.med@ssss.gouv.qc.ca

More Information

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital

Last update posted

May 14, 2026

Last verified

May, 2025

Keywords

  • Colorectal cancer
  • Treatment preferences

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Sir Mortimer B. Davis - Jewish General Hospital on 2026-05-14.